Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 450 du 19 mai 2020
Qualité de vie, soins de support (13)
Menée au Canada à partir de données portant sur 788 patients atteints d’un cancer métastatique de l’estomac diagnostiqué entre 2007 et 2014, cette étude de cohorte rétrospective analyse l’évolution de leurs symptômes durant les 6 derniers mois de vie
Patient-reported symptoms in metastatic gastric cancer patients in the last 6 months of life
Menée au Canada à partir de données portant sur 788 patients atteints d’un cancer métastatique de l’estomac diagnostiqué entre 2007 et 2014, cette étude de cohorte rétrospective analyse l’évolution de leurs symptômes durant les 6 derniers mois de vie
Patient-reported symptoms in metastatic gastric cancer patients in the last 6 months of life
Lev D. Bubis, Victoria Delibasic, Laura E. Davis, Yunni Jeong (et al.)
Background : Patients with metastatic gastric cancer have poor survival outcomes and may experience high symptom burden. We evaluated symptom trajectory and risk factors for increased symptom severity among metastatic gastric cancer patients during the last 6 months of life. Methods : We conducted a retrospective cohort study among patients ??18 years diagnosed with metastatic gastric cancer from January 2007 to December 2014 in the province of Ontario, Canada. We included patients who died [...]
Cette étude internationale présente les développements récents et l’utilisation des technologies de e-santé dans les soins de support en cancérologie
Advances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposium
Cette étude internationale présente les développements récents et l’utilisation des technologies de e-santé dans les soins de support en cancérologie
Advances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposium
Raymond J. Chan, Doris Howell, Maryam B. Lustberg, Karen Mustian (et al.)
Purpose : The role of mobile health (mHealth) technology in cancer care has evolved alongside the rapid development in digital technology. Its use can come with significant potential benefits; however, such use may also be associated with risks. This paper summarizes the latest developments around mHealth use in cancer care presented by a panel of experts at the 2019 Annual Meeting of the Multinational Association of Supportive Care in Cancer. Methods : Through lectures, case studies, and panel [...]
Menée en Italie à partir de données portant sur 236 patients atteints d’un cancer de stade avancé, cette étude analyse l’association entre des difficultés financières, des symptômes physiques et psychiques liés à la maladie et la qualité de vie
Financial distress and its impact on symptom expression in advanced cancer patients
Menée en Italie à partir de données portant sur 236 patients atteints d’un cancer de stade avancé, cette étude analyse l’association entre des difficultés financières, des symptômes physiques et psychiques liés à la maladie et la qualité de vie
Financial distress and its impact on symptom expression in advanced cancer patients
Sebastiano Mercadante, Federica Aielli, Claudio Adile (et al.)
Aim : To assess financial distress (FD) and its impact on symptom expression and other quality of life issues. Patients and methods : Advanced cancer patients admitted to inpatient and outpatient clinics were selected. Standard epidemiological data including age, gender, primary cancer diagnosis, and Karnofsky level were recorded. Data regarding marital status, number of cohabitants, religious belief, educational level, and family income (1000, 1000–3.000, >?3000 euros), as well as extra [...]
Ces deux articles américains soulignent l’importance d’évaluer les bénéfices et les risques de l’utilisation des opioïdes pour soulager la douleur chez des patients atteints d’un cancer
Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016 : A Population Study of the Opioid Epidemic
Ces deux articles américains soulignent l’importance d’évaluer les bénéfices et les risques de l’utilisation des opioïdes pour soulager la douleur chez des patients atteints d’un cancer
Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006-2016 : A Population Study of the Opioid Epidemic
Fumiko Chino, Arif Kamal, Junzo Chino (et al.)
More than 40?000 people in the US died owing to opioids in 2016; the epidemic tops public health concerns. Opioids are commonly used for cancer-associated pain, and there has been a call for oncologists to become more aware of opioid-related risks and benefits.1 It is unknown, however, if opioid-related deaths in cancer survivors are rising at the same rate as in the general population.
Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hem...
Ces deux articles américains soulignent l’importance d’évaluer les bénéfices et les risques de l’utilisation des opioïdes pour soulager la douleur chez des patients atteints d’un cancer
Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist
Ilana Graetz, Courtney R. Yarbrough, Xin Hu (et al.)
More than 30 states have enacted laws mandating use of prescription drug monitoring programs (PDMP) to reduce inappropriate opioid prescribing. Clinicians in those states must check the PDMP database before writing opioid prescriptions. These mandates vary substantially across states in their timing and scope; for example, some exempt patients with cancer.1,2 We examine the association between state mandatory-access PDMPs and changes in the percent of oncologists’ Medicare patients with any [...]
Managing Cancer Pain During the Opioid Epidemic—Balancing Caution and Compassion
Ces deux articles américains soulignent l’importance d’évaluer les bénéfices et les risques de l’utilisation des opioïdes pour soulager la douleur chez des patients atteints d’un cancer
Managing Cancer Pain During the Opioid Epidemic—Balancing Caution and Compassion
Lucas K. Vitzthum, Paul Riviere, James D. Murphy
Opioid prescribing patterns have come under increased scrutiny in the setting of the ongoing opioid epidemic as rates of opioid prescription, overdose, and mortality have risen in the United States.1 The opioid epidemic has appropriately led to new guidelines, regulations, and policies that attempt to curtail the inappropriate use of opioids in clinical practice. However, these policies in part arise from prior research of opioid-related adverse effects in the noncancer population, and we lack [...]
A partir d’une revue systématique de la littérature (2 607 patients), cette méta-analyse évalue l’efficacité des anticoagulants oraux directs pour réduire le risque de maladie thromboembolique veineuse chez des patients atteints d’un cancer
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
A partir d’une revue systématique de la littérature (2 607 patients), cette méta-analyse évalue l’efficacité des anticoagulants oraux directs pour réduire le risque de maladie thromboembolique veineuse chez des patients atteints d’un cancer
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Frits I. Mulder, Floris T.M. Bosch, Annie M. Young, Andrea Marshall (et al.)
Direct oral anticoagulants (DOACs) are an emerging treatment option for cancer patients with acute venous thromboembolism (VTE), but studies have reported inconsistent results. This systematic review and meta-analysis compared the efficacy and safety of DOACs and low-molecular-weight heparins (LMWH) in these patients. MEDLINE, Embase, CENTRAL, and conference proceedings were searched to identify relevant randomized controlled trials. Additional data were obtained from the original authors to [...]
Mené sur 30 patients atteints d’un cancer de stade avancé (âge moyen : 63 ans), cet essai randomisé évalue l’efficacité de l’olanzapine pour réduire et traiter les nausées et vomissements chroniques (non liés à la chimiothérapie)
Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting : A Randomized Pilot Trial
Mené sur 30 patients atteints d’un cancer de stade avancé (âge moyen : 63 ans), cet essai randomisé évalue l’efficacité de l’olanzapine pour réduire et traiter les nausées et vomissements chroniques (non liés à la chimiothérapie)
Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or Vomiting : A Randomized Pilot Trial
Rudolph M. Navari, Cameron M. Pywell, Jennifer G. Le-Rademacher (et al.)
Importance : Nausea and vomiting, unrelated to chemotherapy, can be substantial symptoms in patients with advanced cancer. Objective : To evaluate the utility of olanzapine for treating chronic nausea/vomiting, unrelated to chemotherapy, in patients with advanced cancer. Design, Setting, and Participants : This study is a double-line, placebo-controlled, randomized clinical trial conducted from July 2017 through April 2019, with analysis conducted in 2019. Eligible participants were outpatients [...]
Mené sur 218 patients atteints d’un cancer du poumon inopérable de stade avancé, cet essai randomisé évalue l’efficacité, du point de vue de la modification de l'absorption maximale d'oxygène, de l’amélioration de la force musculaire et des capacités fonctionnelles, de la réduction des symptômes d’anxiété et de dépression, d’un programme à base d’exercices physiques pendant 12 semaines
Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial
Mené sur 218 patients atteints d’un cancer du poumon inopérable de stade avancé, cet essai randomisé évalue l’efficacité, du point de vue de la modification de l'absorption maximale d'oxygène, de l’amélioration de la force musculaire et des capacités fonctionnelles, de la réduction des symptômes d’anxiété et de dépression, d’un programme à base d’exercices physiques pendant 12 semaines
Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial
Morten Quist, Seppo W. Langer, Christian Lillelund (et al.)
Objective : Exercise can improve treatment-related side effects, quality of life, and function in patients with various types of cancer; however, more evidence is needed for patients with advanced inoperable lung cancer. Material and methods : We randomized 218 patients with advanced inoperable lung cancer to a 12-week supervised, structured exercise training program (aerobic, strength, and relaxation training) twice weekly versus usual care. Primary outcome was change in maximal oxygen uptake [...]
A partir d’une revue systématique de la littérature publiée entre 1998 et 2019 (10 études, 835 patients), cette étude analyse les effets des exercices physiques sur les symptômes et la qualité de vie chez des patients atteints d’un cancer du poumon
Exercise prescription for symptoms and quality of life improvements in lung cancer patients: a systematic review
A partir d’une revue systématique de la littérature publiée entre 1998 et 2019 (10 études, 835 patients), cette étude analyse les effets des exercices physiques sur les symptômes et la qualité de vie chez des patients atteints d’un cancer du poumon
Exercise prescription for symptoms and quality of life improvements in lung cancer patients: a systematic review
Alberto Codima, Willian das Neves Silva, Ana Paula de Souza Borges (et al.)
Purpose :The purpose of this study was to conduct a systematic review to assess the effect of exercise on symptoms and quality of life in lung cancer patients. Methods : We conducted a systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Medline, Embase, Scopus, Web of Science, and SciELO were searched for studies published from January 1998 to January 2019. The review included all randomized controlled trials that evaluated the [...]
Menée aux Etats-Unis à partir de données portant sur 89 patients ayant survécu à un cancer de la prostate, cette étude de cohorte rétrospective analyse les facteurs cliniques et psychosociaux associés à la pratique d’une activité physique
Social and clinical determinants of physical activity in prostate cancer survivors
Menée aux Etats-Unis à partir de données portant sur 89 patients ayant survécu à un cancer de la prostate, cette étude de cohorte rétrospective analyse les facteurs cliniques et psychosociaux associés à la pratique d’une activité physique
Social and clinical determinants of physical activity in prostate cancer survivors
Chanita Hughes Halbert, Melanie S. Jefferson, Richard Drake, Michael Lilly (et al.)
Purpose : Physical activity is important for enhancing quality of life and cancer control among prostate cancer survivors. The purpose of this study was to characterize adherence to physical activity guidelines among African American and white prostate cancer survivors based on social and clinical determinants and psychosocial factors. Methods : Observational study of meeting guidelines for moderate intensity physical activity in a retrospective cohort of African American and white prostate [...]
Menée aux Etats-Unis par entretiens téléphoniques auprès de 403 patients ayant survécu plus de 5 ans à un cancer colorectal et menée auprès de 401 témoins, cette étude analyse l’impact de comorbidités sur la qualité de vie
Quality of life and the negative impact of comorbidities in long-term colorectal cancer survivors: a population-based comparison
Menée aux Etats-Unis par entretiens téléphoniques auprès de 403 patients ayant survécu plus de 5 ans à un cancer colorectal et menée auprès de 401 témoins, cette étude analyse l’impact de comorbidités sur la qualité de vie
Quality of life and the negative impact of comorbidities in long-term colorectal cancer survivors: a population-based comparison
Amy Pate, Jan Lowery, Kristin Kilbourn, Patrick J. Blatchford (et al.)
Purpose : Colorectal cancer (CRC) is the third most common cancer in the USA. The objective of this study was to compare quality of life (QoL) across long-term colorectal cancer survivors and unaffected matched controls while adjusting for comorbidities. Methods : The National Cancer Institute (NCI)-funded Colon Cancer Family Registry (CCFR) was used to randomly select and recruit CRC survivors (??5 years from diagnosis) and matched controls for a cross-sectional survey. Nine geographically [...]
Menée au Canada par enquête auprès de 463 patients ayant survécu à un cancer du rein, cette étude analyse l’effet de l'augmentation de l'activité physique ou du sommeil sur la qualité de vie
Replacing sedentary time with physical activity and sleep: associations with quality of life in kidney cancer survivors
Menée au Canada par enquête auprès de 463 patients ayant survécu à un cancer du rein, cette étude analyse l’effet de l'augmentation de l'activité physique ou du sommeil sur la qualité de vie
Replacing sedentary time with physical activity and sleep: associations with quality of life in kidney cancer survivors
Allyson Tabaczynski, Kerry S. Courneya, Linda Trinh
Purpose : Kidney cancer survivors spend large quantities of time sedentary and little time physically active, which negatively impacts quality of life (QoL). This study examined (1) the association of reallocating sedentary time to sleep, light physical activity (PA), or moderate-to-vigorous PA (MVPA) on QoL in kidney cancer survivors and (2) the threshold at which results are clinically meaningful. Methods : Kidney cancer survivors (N?=?463) completed a survey including the Godin Leisure-Time [...]
Menée au Japon auprès de 143 patientes atteintes d’un cancer du sein, cette étude prospective évalue l’efficacité, pour prévenir le risque d'alopécie, d’un dispositif de refroidissement du cuir chevelu pendant une chimiothérapie adjuvante ou néoadjuvante
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy
Menée au Japon auprès de 143 patientes atteintes d’un cancer du sein, cette étude prospective évalue l’efficacité, pour prévenir le risque d'alopécie, d’un dispositif de refroidissement du cuir chevelu pendant une chimiothérapie adjuvante ou néoadjuvante
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy
Shozo Ohsumi, Sachiko Kiyoto, Mina Takahashi (et al.)
Purpose : Scalp cooling during chemotherapy infusion has been recently reported to have moderate efficacy in the mitigation of chemotherapy-induced alopecia; however, there are few reports on Asian patients. We aimed to clarify the effects of scalp cooling in Japanese women. Patients and methods : Female Japanese breast cancer patients who planned to receive (neo)adjuvant chemotherapy participated in this prospective study on the efficacy of scalp cooling using the Paxman Scalp Cooling System [...]
Menée à partir de l'analyse, à l’aide d’un algorithme d’apprentissage automatique, de données génomiques portant sur 2 799 patientes ayant survécu à un cancer du sein de stade précoce, cette étude de cohorte identifie les facteurs prédictifs d’une fatigue liée aux traitements anticancéreux
Prediction of Breast Cancer Treatment-Induced Fatigue by Machine Learning Using Genome Wide Association Data
Menée à partir de l'analyse, à l’aide d’un algorithme d’apprentissage automatique, de données génomiques portant sur 2 799 patientes ayant survécu à un cancer du sein de stade précoce, cette étude de cohorte identifie les facteurs prédictifs d’une fatigue liée aux traitements anticancéreux
Prediction of Breast Cancer Treatment-Induced Fatigue by Machine Learning Using Genome Wide Association Data
Sangkyu Lee, PhD, Joseph O Deasy, PhD, Jung Hun Oh, PhD, Antonio Di Meglio (et al.)
Background : We aimed at predicting fatigue after breast cancer (BC) treatment, using machine learning on clinical covariates and germline genome-wide data. Methods : We accessed germline genome-wide data of 2799 early-stage BC patients from CANTO (NCT01993498). The primary endpoint was defined as scoring zero at diagnosis and higher than quartile-3 at 1 year after primary treatment completion, on EORTC-QLQ-C30 for overall fatigue and on the multidimensional EORTC-QLQ-FA12 for physical, [...]
Observation (15)
Menée aux Etats-Unis à partir de données portant sur 28 060 patients atteints d’un cancer et hospitalisés pour une fièvre neutropénique, cette étude de cohorte rétrospective analyse l’effet de comorbidités cardiovasculaires sur le risque de décès durant l'hospitalisation
Impact of cardiovascular comorbidities on inpatient mortality in patients hospitalized with neutropenic fever
Menée aux Etats-Unis à partir de données portant sur 28 060 patients atteints d’un cancer et hospitalisés pour une fièvre neutropénique, cette étude de cohorte rétrospective analyse l’effet de comorbidités cardiovasculaires sur le risque de décès durant l'hospitalisation
Impact of cardiovascular comorbidities on inpatient mortality in patients hospitalized with neutropenic fever
Suheil Albert Atallah-Yunes, Anis John Kadado, Faris Haddadin, Khalid Sawalha (et al.)
Introduction : Concomitant cardiovascular comorbidities in patients with cancer are not uncommon. There is limited data on the impact of cardiovascular comorbidities on in-hospital mortality in patients admitted with neutropenic fever. Methods : This is a retrospective cohort study using the 2016 NIS database of adults (>?18 years old) hospitalized for neutropenic fever as the primary diagnosis. The primary outcome studied is all-cause mortality in patients with neutropenic fever. ICD-10-CM [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
M.Montopoli, S.Zumerle, R.Vettor (et al.)
Background : Cell entry of SARS-CoV-2 depends on binding of the viral spike (S) proteins to ACE2 and on S protein priming by TMPRSS2. Inhibition of TMPRSS2 may work to block or decrease the severity of SARS-CoV-2 infections. Intriguingly, TMPRSS2 is an androgen-regulated gene that is upregulated in prostate cancer where it supports tumor progression and is involved in a frequent genetic translocation with the ERG gene. First- or second-generation androgen-deprivation therapies (ADTs) decrease [...]
Lessons to Europe from China for cancer treatment during the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Lessons to Europe from China for cancer treatment during the COVID-19 pandemic
Ling Peng, Jin-Song Yang, Justin Stebbing
While cancer patients might have a higher risk of harm compared with patients without cancer if infected with SARS–CoV2,1,2 the degree of elevated risks if any remains uncertain and will be based on numerous host-, tumour- and treatment-related factors. Compared with the European medical system, there are some measures worth learning from China, from our experience working with cancer patients during the pandemic. (...)
Cancer treatment during COVID-19 pandemic: do not postpone, do it!
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer treatment during COVID-19 pandemic: do not postpone, do it!
Claudia Omarini, Michela Maur, Gabriele Luppi (et al.)
At the end of January 2020, a novel beta-coronavirus, known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), progressively spread in Italy. Patients with cancer are considered more prone to infections because of the immunosuppressive status due to both malignancy and anticancer treatments. From the first Italian government restrictions (23rd February), Modena Cancer Center adopted practical health vigilance recommendations in order to minimize the virus exposure risk without [...]
Risk of COVID-19 in patients treated for cancer: an immune response-based hypothesis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Risk of COVID-19 in patients treated for cancer: an immune response-based hypothesis
Michela Roberto, Fabio Basta, Federica Mazzuca (et al.)
Despite a considerable increase of new coronavirus (SARS-CoV-2) related publications, there are still few data to quantify the risk of infection in patients under treatment for cancer. Reports from the epicenter of the viral epidemic show in cancer patients a risk of infection and a mortality rate of about 2% and 4% respectively.(...)
Arterial Thrombosis and Covid-19 in a Cancer patient
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Arterial Thrombosis and Covid-19 in a Cancer patient
Rami Nassabein, Bertrand Routy, Normand Blais (et al.)
Preliminary reports have pointed out to an increased risk of thrombotic events in patients diagnosed with coronavirus disease 2019 (Covid-19)(1, 2) and optimal prophylactic strategies remain unknow. Herein, we report the case of a cancer patient, positive for Covid-19 who developed an extensive intra-aortic thrombosis.
Cessation of cancer screening: An unseen cost of the COVID-19 pandemic?
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cessation of cancer screening: An unseen cost of the COVID-19 pandemic?
Ker-Kan Tan, Jerrald Lau
The world continues to struggle with COVID-19. Based on figures from countries such as Korea, Australia and New Zealand that do extensive testing, the mortality rate of COVID-19 is nonetheless less than 2%, and this is likely to be lower due to the many more undiagnosed COVID-19 cases worldwide. Cancer, on the other hand, remains one of the leading causes of death, and a number of recent publications with the European Journal of Surgical Oncology have rightly highlighted the impact of COVID-19 [...]
COVID-19 and cancer: Looking for evidence
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 and cancer: Looking for evidence
Diego Serraino
How will COVID-19 outbreak impact on millions of individuals already living with cancer and on those who will be newly diagnosed with cancer in every country of the world? A question widely brought to public attention by the international cancer community and the media, with more than 500 articles (from guidelines on how to manage cancer cases to clinical case reports) published between March and April 2020 in the scientific literature. The disruption caused by coronavirus on health systems has [...]
Palliative Care for Patients With Cancer in the COVID-19 Era
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Palliative Care for Patients With Cancer in the COVID-19 Era
Ambereen K. Mehta, Thomas J. Smith
With early studies suggesting that patients with active cancer are particularly susceptible to COVID-19, the current pandemic is forcing palliative care health care professionals to better define our identity as a field.1 With social distancing requirements, should we minimize patient contact to keep our patients and ourselves safe? As a relatively new specialty, are palliative care consults a luxury that we can hold off on to avoid overburdening the medical system? Are we essential medical [...]
COVID-19 in Children With Cancer in New York City
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 in Children With Cancer in New York City
Farid Boulad, Mini Kamboj, Nancy Bouvier (et al.)
Data on the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children,1-4 and in children with cancer specifically have been limited. Less than 1% of cases reported from China were in children younger than 10 years.3 The MSK Kids pediatric program at Memorial Sloan Kettering Cancer Center (MSK) is one of the largest pediatric cancer programs in the US. Starting in mid-March, 2020, we instituted a screening and testing plan to mitigate risk associated with [...]
Cancer and Coronavirus Disease 2019 (COVID-19)- Facing the “C Words”
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer and Coronavirus Disease 2019 (COVID-19)- Facing the “C Words”
Urvi A. Shah
Until now, most people feared a diagnosis with the dreaded “C word”—cancer—owing to its associated physical, emotional, and financial hardships as well as its social stigma. However, the rapid progression of coronavirus disease 2019 (COVID-19) from a local issue to a global pandemic has quickly made it a competitor for the spot of the most feared disease, and rightly so, given the intense strain it is placing on us individually and as a society at every level. For me, having been diagnosed with [...]
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic
Davide Mauri, Konstantinos Kamposioras, Maria Tolia (et al.)
Patients with cancer are at high risk for serious illness and death from COVID-19. The pandemic has altered the routine for oncology patients. Their lives depend on their ability to receive medical care, but every visit to a health-care facility exposes them to the risk of contracting the virus; therefore, concerns about getting infected might interfere with their continuity of care. Does oncology treatment outweigh the risk of infection? The psychological pressure of uncertainty for patients [...]
Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America
Liliana Vasquez, Claudia Sampor, Gabriela Villanueva (et al.)
Although previous studies have suggested that the complications and mortality rate related to COVID-19 are substantially lower in the paediatric population, it is reasonable to consider that children with underlying conditions such as cancer will be at increased risk of severe disease. Some reports have examined the impact of COVID-19 in children with cancer; in all cases no deaths or disease-related complications have been reported.In order to prevent the rapid spread of the virus as seen in [...]
Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: a single-center experience
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: a single-center experience
David Rossi
Coronavirus pandemic disease forced clinicians and health systems to radically change treatments of oncological patients, especially patients with advanced lung cancer without oncogene-drivers. During Covid19 pandemic, oncologists worldwide must choose the best strategy for these “frail” patients in order to reduce side effects and maximize the outcomes. ESMO-Guidelines during Covid19 era shows HIGH PRIORITY for “1st-line treatment including chemotherapy, chemotherapy plus Immunotherapy, [...]
Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire?
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immune checkpoint inhibitors in SARS-COV-2 infected cancer patients: the spark that ignites the fire?
Vincenzo Di Noia, Alessandro D’Aveni, Michela Squadroni (et al.)
Since December 2019, a novel coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially reported un Wuhan, China, rapidly spread in other 114 countries worldwide, becoming pandemic. In general, COVID-19 is acute resolved disease but it can also be deadly, mainly in older people and those with underlying medical conditions, such as cardiovascular disease and cancer. Cancer patients are at high risk of developing severe COVID-19 illness, [...]
Menée aux Etats-Unis à partir de données portant sur 630 patients ayant survécu à un myélome multiple et ayant reçu une greffe autologue de cellules souches hématopoïétiques, cette étude analyse le risque à 10 ans de maladies chroniques et de nouveaux cancers
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study
Menée aux Etats-Unis à partir de données portant sur 630 patients ayant survécu à un myélome multiple et ayant reçu une greffe autologue de cellules souches hématopoïétiques, cette étude analyse le risque à 10 ans de maladies chroniques et de nouveaux cancers
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study
Mukta Arora, Yanjun Chen, Lindsey Hageman (et al.)
BACKGROUND : Autologous blood or bone marrow transplantation (aBMT) is considered the standard of care for patients with multiple myeloma (MM). Significantly improved survival necessitates an understanding of the morbidity burden borne by the growing survivor population. METHODS : The authors evaluated severe and/or life?threatening chronic health conditions (CHCs) and subsequent neoplasms (SNs) in patients with MM who were treated with aBMT using the Bone Marrow Transplant Survivor Study. A [...]
Menée aux Etats-Unis par enquête sur la période 2013-2017 auprès de 12 648 patients ayant survécu à un cancer, cette étude analyse leurs comportements de santé (tabagisme, activité physique, consommation d’alcool, durée du sommeil, etc.)
Prevalence of Healthy Behaviors among Cancer Survivors in the United States: How Far Have We Come?
Menée aux Etats-Unis par enquête sur la période 2013-2017 auprès de 12 648 patients ayant survécu à un cancer, cette étude analyse leurs comportements de santé (tabagisme, activité physique, consommation d’alcool, durée du sommeil, etc.)
Prevalence of Healthy Behaviors among Cancer Survivors in the United States: How Far Have We Come?
Hannah Arem, Scherezade K. Mama, Xuejing Duan, Julia H. Rowland, Keith M. Bellizzi and Diane K. Ehlers
Background: The 16.9 million cancer survivors in the United States are at increased risk for comorbidities and recurrence. However, this risk may be attenuated by a healthy lifestyle. This study describes health behaviors by cancer history to inform behavior change priorities. Methods: We analyzed 2013–2017 data from the National Health Interview Survey. There were 164,692 adults, of whom 12,648 reported a cancer history. We calculated prevalence of smoking, physical activity, alcohol [...]
Menée aux Etats-Unis à partir de données portant sur 2 444 enfants (âge : 0-14 ans) et sur 13 459 adolescents et jeunes adultes (âge : 15-39 ans) atteints d’un cancer diagnostiqué entre 1986 et 2015, cette étude analyse l’association entre la pollution atmosphérique par les particules fines et la mortalité par type de cancer
Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients
Menée aux Etats-Unis à partir de données portant sur 2 444 enfants (âge : 0-14 ans) et sur 13 459 adolescents et jeunes adultes (âge : 15-39 ans) atteints d’un cancer diagnostiqué entre 1986 et 2015, cette étude analyse l’association entre la pollution atmosphérique par les particules fines et la mortalité par type de cancer
Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients
Judy Y. Ou, Heidi A. Hanson, Joemy M. Ramsay, Heydon K. Kaddas (et al.)
Background: Air pollution is a carcinogen and causes pulmonary and cardiac complications. We examined the association of fine particulate matter pollution (PM2.5) and mortality from cancer and all causes among pediatric, adolescent, and young adult (AYA) patients with cancer in Utah, a state with considerable variation in PM2.5.Methods: We followed 2,444 pediatric (diagnosed ages 0–14) and 13,459 AYA (diagnosed ages 15–39) patients diagnosed in 1986–2015 from diagnosis to 5 and 10 years [...]
A partir d’une revue de la littérature (20 articles), cette étude analyse l’effet, sur la composition corporelle, d’une greffe allogénique de cellules souches hématopoïétiques suivie d’une radiothérapie du corps entier chez des enfants, adolescents et jeunes adultes atteints d'une leucémie (âge : 0-24 ans)
Body composition after allogeneic haematopoietic cell transplantation/total body irradiation in children and young people: a restricted systematic...
A partir d’une revue de la littérature (20 articles), cette étude analyse l’effet, sur la composition corporelle, d’une greffe allogénique de cellules souches hématopoïétiques suivie d’une radiothérapie du corps entier chez des enfants, adolescents et jeunes adultes atteints d'une leucémie (âge : 0-24 ans)
Body composition after allogeneic haematopoietic cell transplantation/total body irradiation in children and young people: a restricted systematic review
Ava Lorenc, Julian Hamilton-Shield, Rachel Perry, Michael Stevens (et al.)
Purpose : To collate evidence of changes in body composition following treatment of leukaemia in children, teenagers and young adults (CTYA, 0–24 years) with allogeneic haematopoietic stem cell transplant and total body irradiation (HSCT+TBI). Methods : Papers were identified by searching Medline and Google Scholar, reference lists/citations and contacting key authors, with no date or language restrictions. Inclusion criteria were as follows: leukaemia, HSCT+TBI, aged ??24 years at HSCT and [...]
Menée à partir des données des registres des cancers de 68 pays sur la période 1983-2012, cette étude internationale analyse les disparités géographiques dans l’évolution de l’incidence du cancer de la vulve et du cancer du vagin
Geographic and temporal variations in the incidence of vulvar and vaginal cancers
Menée à partir des données des registres des cancers de 68 pays sur la période 1983-2012, cette étude internationale analyse les disparités géographiques dans l’évolution de l’incidence du cancer de la vulve et du cancer du vagin
Geographic and temporal variations in the incidence of vulvar and vaginal cancers
Freddie Bray, Mathieu Laversanne, Elisabete Weiderpass, Marc Arbyn MD (et al.)
Vulvar and vaginal cancers are relatively rare cancers, together responsible for 1.5% of the global cancer incidence among women in 2018. The majority of vaginal cancers, and a lesser proportion of vulvar cancers are associated with HPV. Various reports have indicated rising incidence rates of vulvar cancer in younger women, possibly due to an increased prevalence of high?risk HPV types. This report assesses recent international variations in the incidence rates of vulvar and vaginal cancer [...]
Menée dans les 50 Etats américains sur la période 2001-2016, cette étude analyse l’évolution de l’incidence de l’adénocarcinome du pancréas, en fonction du sexe et de l’origine ethnique
Trends in the incidence of pancreatic adenocarcinoma in all 50 United States examined through an age-period-cohort analysis
Menée dans les 50 Etats américains sur la période 2001-2016, cette étude analyse l’évolution de l’incidence de l’adénocarcinome du pancréas, en fonction du sexe et de l’origine ethnique
Trends in the incidence of pancreatic adenocarcinoma in all 50 United States examined through an age-period-cohort analysis
Wilson L da Costa, Jr, Abiodun O Oluyomi, Aaron P Thrift
Background : Pancreatic ductal adenocarcinoma (PDAC) is a major contributor to cancer-related mortality in the U.S. We aimed to investigate trends in incidence rates from all 50 states from 2001 to 2016, overall and by race, sex, and state, and using age-period-cohort analyses. Methods : Age-adjusted incidence rates and trends in adults aged ?35 years were calculated using data from the U.S. Cancer Statistics registry. We used joinpoint regression to compute annual percent changes (APC) and [...]
Menée à partir des données 2004-2012 des registres américains des cancers portant sur 458 132 patients atteints d’un cancer du poumon, cette étude analyse l’évolution des facteurs associés au risque de développer la maladie en fonction du sexe
Gender and Lung Cancer- SEER based analysis
Menée à partir des données 2004-2012 des registres américains des cancers portant sur 458 132 patients atteints d’un cancer du poumon, cette étude analyse l’évolution des facteurs associés au risque de développer la maladie en fonction du sexe
Gender and Lung Cancer- SEER based analysis
Yaakov Tolwin, Roni Gillis, Nir Peled
Background : Lung cancer remains a major cause of death worldwide. While in the past it was considered to primarily afflict males, in recent decades the number of female patients has risen, such that rates among females are similar to those among males. Nevertheless, it has been found previously (e.g. in cardiovascular disease) that when there is a sex specific stereotype to a disease, it may remain entrenched in medical diagnostic processes, so as to cause belated diagnosis among the other [...]
Menée en Angleterre à partir des données d’un registre des cancers portant sur 57 373 patients atteints d’un cancer du poumon non à petites cellules de stade I à IIIA diagnostiqué entre 2012 et 2016, cette étude analyse l’association entre les disparités géographiques dans les taux de résection, la présence de comorbidités cardiovasculaires et la survie à 1 an
Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a...
Menée en Angleterre à partir des données d’un registre des cancers portant sur 57 373 patients atteints d’un cancer du poumon non à petites cellules de stade I à IIIA diagnostiqué entre 2012 et 2016, cette étude analyse l’association entre les disparités géographiques dans les taux de résection, la présence de comorbidités cardiovasculaires et la survie à 1 an
Impact on survival of modelling increased surgical resection rates in patients with non-small-cell lung cancer and cardiovascular comorbidities: a VICORI study
Catherine A. Welch, Michael J. Sweeting, Paul C. Lambert (et al.)
Background : The impact of cardiovascular disease (CVD) comorbidity on resection rates and survival for patients with early-stage non-small-cell lung cancer (NSCLC) is unclear. We explored if CVD comorbidity explained surgical resection rate variation and the impact on survival if resection rates increased. Methods :Cancer registry data consisted of English patients diagnosed with NSCLC from 2012 to 2016. Linked hospital records identified CVD comorbidities. We investigated resection rate [...]
A partir d’une revue systématique de la littérature (20 articles, 3 553 patients), cette étude analyse les facteurs associés aux troubles neurocognitifs chez des patients atteints d’un cancer du poumon traité par irradiation crânienne prophylactique
Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review
A partir d’une revue systématique de la littérature (20 articles, 3 553 patients), cette étude analyse les facteurs associés aux troubles neurocognitifs chez des patients atteints d’un cancer du poumon traité par irradiation crânienne prophylactique
Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review
Haiyan Zeng,Lizza E.L. Hendriks, Wouter H. van Geffen
Background : Prophylactic cranial irradiation (PCI) reduces brain metastasis incidence in lung cancer, however with risk of neurocognitive decline. Nevertheless, risk factors for neurocognitive decline after PCI remain unclear. Methods : We systematically reviewed the PubMed database according to the PRISMA guideline. Included were: randomized clinical trials (RCTs) and observational/single arm trials evaluating PCI, including ?20 patients, reporting neurocognitive test results for lung cancer. [...]
Menée au Royaume-Uni à partir de données portant sur 1 224 patients atteints d’un cancer du poumon non à petites cellules traité par radiothérapie radicale entre 2010 et 2016, cette étude de cohorte rétrospective analyse le risque de développer une maladie cardiovasculaire en lien avec la radiothérapie, puis évalue la mortalité par maladie cardiovasculaire
Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: is cardiovascular death under-reported?
Menée au Royaume-Uni à partir de données portant sur 1 224 patients atteints d’un cancer du poumon non à petites cellules traité par radiothérapie radicale entre 2010 et 2016, cette étude de cohorte rétrospective analyse le risque de développer une maladie cardiovasculaire en lien avec la radiothérapie, puis évalue la mortalité par maladie cardiovasculaire
Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: is cardiovascular death under-reported?
F. Sun, K. Franks, L. Murray (et al.)
Background : Lung cancer is the most common malignancy worldwide. Radical radiotherapy is an essential treatment in the management of early and locally advanced lung cancer. Cardiac events are known to occur following radical radiotherapy for lung cancer. This study examines the burden of cardiac events post radiotherapy, and estimates the accuracy of death certification in patients who received radical radiotherapy for lung cancer. Methods : We conducted a retrospective observational cohort [...]
Menée à partir des données des registres américains des cancers portant sur 109 608 patientes atteintes d’un cancer du sein diagnostiqué après 65 ans entre 2000 et 2011, cette étude analyse l’association entre le lieu de résidence (zone rurale ou urbaine) et l’utilisation des soins de santé ainsi que la survie globale
Urban versus Rural Residence and Outcomes in Older Patients with Breast Cancer
Menée à partir des données des registres américains des cancers portant sur 109 608 patientes atteintes d’un cancer du sein diagnostiqué après 65 ans entre 2000 et 2011, cette étude analyse l’association entre le lieu de résidence (zone rurale ou urbaine) et l’utilisation des soins de santé ainsi que la survie globale
Urban versus Rural Residence and Outcomes in Older Patients with Breast Cancer
Kelly M. Kenzik, Gabrielle B. Rocque, Wendy Landier, Smita Bhatia
Background: A total of 20% of the U.S. population resides in rural areas, yet is served by 3% of oncologists, and 7% of nononcology specialists. Access to care issues can be compounded by lower socioeconomic status (SES) in rural areas, yet this issue is unexplored among older patients with breast cancer. Methods: Using Surveillance Epidemiology and End Results-Medicare, 109,608 patients diagnosed at ?65 years with breast cancer between 2000 and 2011 were identified. Residence status was [...]
Menée aux Etats-Unis à partir des données de 51 registres des cancers portant sur 126 575 patients atteints d’une tumeur à cellules germinales du testicule, cette étude analyse les disparités ethniques dans l’évolution de l’incidence de la maladie sur la période 2001-2016
Increasing Incidence of Testicular Germ Cell Tumors Among Racial/Ethnic Minorities in the United States
Menée aux Etats-Unis à partir des données de 51 registres des cancers portant sur 126 575 patients atteints d’une tumeur à cellules germinales du testicule, cette étude analyse les disparités ethniques dans l’évolution de l’incidence de la maladie sur la période 2001-2016
Increasing Incidence of Testicular Germ Cell Tumors Among Racial/Ethnic Minorities in the United States
Armen A. Ghazarian, Katherine A. McGlynn
Background: The incidence of testicular germ cell tumors (TGCT) has been rising in the United States and is notably higher among white men. Previously, our group reported that rates were rising among Hispanic men in certain areas. This study sought to determine whether the patterns noted in our prior publication remained evident in more recent years and to determine whether any new patterns have emerged. Methods: Data from 51 U.S. cancer registries were examined. Racial/ethnic-specific [...]
A partir d’une revue systématique de la littérature publiée jusqu’en 2019 (26 articles), cette méta-analyse évalue le risque de développer un second cancer métachrone chez des patients ayant survécu à un cancer des voies aérodigestives supérieures
Occurrence of metachronous second primary cancer in head and neck cancer survivors: A systematic review and meta-analysis of the literature
A partir d’une revue systématique de la littérature publiée jusqu’en 2019 (26 articles), cette méta-analyse évalue le risque de développer un second cancer métachrone chez des patients ayant survécu à un cancer des voies aérodigestives supérieures
Occurrence of metachronous second primary cancer in head and neck cancer survivors: A systematic review and meta-analysis of the literature
Ilda Hoxhaj, Ola Hysaj, Vladimir Vukovic, Emanuele Leoncini (et al.)
Objective : Head and neck cancer (HNC) is the sixth leading cancer worldwide with approximately 600,000 new cases per year. Several studies suggest that HNC survivors may have an increased risk of developing second primary cancers (SPCs). A systematic review and meta?analysis was performed aiming to quantify the overall and site?specific risk of metachronous SPCs in HNC survivors. Methods : PubMed, Web of Science and Scopus were searched to identify studies published until October 2019. Studies [...]
Approches psycho-sociales (3)
Cette étude présente le modèle élaboré par "The American Psychosocial Oncology Society" pour permettre l’accès aux soins psychosociaux dans les services d’oncologie
Framework for Planning the Delivery of Psychosocial Oncology Services: An American Psychosocial Oncology Society Task Force Report
Cette étude présente le modèle élaboré par "The American Psychosocial Oncology Society" pour permettre l’accès aux soins psychosociaux dans les services d’oncologie
Framework for Planning the Delivery of Psychosocial Oncology Services: An American Psychosocial Oncology Society Task Force Report
William F. Pirl, Joseph A. Greer, Sharla Wells?Di Gregorio (et al.)
Objective: While screening for psychosocial distress is now standard of care in oncology, little guidance is available for how best to deliver services in response to identified needs. The American Psychosocial Oncology Society (APOS) convened a task force with the goal of creating a framework which could aid in planning services and justifying requests for resources. Methods: Ten experts from multiple disciplines within psychosocial oncology served on the task force, first meeting together as [...]
Menée aux Etats-Unis, au Canada, au Royaume-Uni et en Australie par enquête en ligne auprès de femmes porteuses de mutations BRCA mais non atteintes d'un cancer (576 répondantes ; âge moyen : 40,8 ans), cette étude analyse les facteurs associés à une détresse psychologique induite par le risque de développer la maladie
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis
Menée aux Etats-Unis, au Canada, au Royaume-Uni et en Australie par enquête en ligne auprès de femmes porteuses de mutations BRCA mais non atteintes d'un cancer (576 répondantes ; âge moyen : 40,8 ans), cette étude analyse les facteurs associés à une détresse psychologique induite par le risque de développer la maladie
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis
Kelly A. Metcalfe, Melanie A. Price, Carol Mansfield, David C. Hallett (et al.)
Background : Women with a BRCA1 or BRCA2 mutation have high lifetime risks of developing breast and ovarian cancers. We sought to estimate the prevalence of cancer-related distress and to identify predictors of distress in an international sample of unaffected women with a BRCA mutation. Methods : Women with a BRCA1/2 mutation and no previous cancer diagnosis were recruited from the United States, Canada, the United Kingdom, Australia and from a national advocacy group. Using an online survey, [...]
A partir d’une revue de la littérature (15 articles), cette étude évalue l’efficacité des interventions psychosociales destinées aux enfants (âge : 0-18 ans) dont un parent est atteint d’un cancer
How psychosocial interventions meet the needs of children of parents with cancer: A review and critical evaluation
A partir d’une revue de la littérature (15 articles), cette étude évalue l’efficacité des interventions psychosociales destinées aux enfants (âge : 0-18 ans) dont un parent est atteint d’un cancer
How psychosocial interventions meet the needs of children of parents with cancer: A review and critical evaluation
Jeneva L. Ohan, Hayley M. Jackson, Samantha Bay (et al.)
Introduction : The aim of this study was to evaluate how psychosocial interventions for children aged 0–18 years of a parent with cancer meet their needs, using key needs as consumer?based “standards.” Methods : A systematic literature review was conducted. Fifteen interventions met inclusion criteria and were assessed against six key needs identified by Ellis et al. (Eur. J. Cancer Care, 26, 2017, e12432): (1) provide children with age?appropriate information about their parent's cancer; (2) [...]
Analyses économiques et systèmes de soins (3)
Menée sur la période 2003-2015, cette étude internationale analyse le rapport coût-efficacité des médicaments anticancéreux en Australie, en France, au Royaume-Uni et aux Etats-Unis
Relationship Between Costs and Clinical Benefits of New Cancer Medicines in Australia, France, the UK, and the US
Menée sur la période 2003-2015, cette étude internationale analyse le rapport coût-efficacité des médicaments anticancéreux en Australie, en France, au Royaume-Uni et aux Etats-Unis
Relationship Between Costs and Clinical Benefits of New Cancer Medicines in Australia, France, the UK, and the US
SebastianSalas-Vega, EmilyShearer, EliasMossialosc
As cancer drug prices rise, it remains unclear whether the cost of new interventions is related to their beneficial impact for patients at a societal-level. Using data for 2003- 2015 from the IQVIA MIDAS® dataset, the relationship between cancer drug costs and drug clinical benefits was studied in four countries with different approaches to drug pricing. Summary measures of drug clinical effects on overall survival, quality of life, and safety were obtained from a review of health technology [...]
Menée en Australie par enquête auprès de 777 patients atteints d’un cancer de stade avancé, cette étude analyse les facteurs associés à leurs perceptions vis-à-vis de l’intérêt et de la valeur financière d’un profilage moléculaire tumoral et leur capacité à payer ce test
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer
Menée en Australie par enquête auprès de 777 patients atteints d’un cancer de stade avancé, cette étude analyse les facteurs associés à leurs perceptions vis-à-vis de l’intérêt et de la valeur financière d’un profilage moléculaire tumoral et leur capacité à payer ce test
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer
Phyllis Butow, Grace Davies, Christine E. Napier (et al.)
Importance : Use of tumor molecular profiling (MP) is entering routine clinical practice; however, little is known about how much and why patients value MP. Objective : To examine the perceived value of MP to patients with advanced cancer and factors associated with perceived value. Design, Setting, and Participants : A cross-sectional survey that included willingness-to-pay trade-off scenarios was administered to participants after consent and before MP. A total of 777 participants (94% [...]
Menée aux Etats-Unis, cette étude analyse l’association entre l’extension de la couverture Medicaid dans le cadre la loi sur la protection des patients et les soins abordables ("Obamacare") et la survie chez des patients atteints d’un cancer du poumon non à petites cellules
Association of Medicaid Expansion Under the Patient Protection and Affordable Care Act With Non–Small Cell Lung Cancer Survival
Menée aux Etats-Unis, cette étude analyse l’association entre l’extension de la couverture Medicaid dans le cadre la loi sur la protection des patients et les soins abordables ("Obamacare") et la survie chez des patients atteints d’un cancer du poumon non à petites cellules
Association of Medicaid Expansion Under the Patient Protection and Affordable Care Act With Non–Small Cell Lung Cancer Survival
Ying Liu, Graham A. Colditz, Benjamin D. Kozower (et al.)
Advances in lung cancer care have improved survival,1 but this has not reached all socioeconomic groups.2,3 Insurance status affects access to early detection and stage-appropriate cancer treatments, which drive survival outcomes. The Patient Protection and Affordable Care Act (ACA) and Medicaid expansion provide health care access to individuals with incomes near federal poverty levels. Medicaid expansion under the ACA was implemented in 2014, substantially reduced the numbers of uninsured [...]
Sensibilisation et communication (2)
Menée aux Pays-Bas par questionnaire auprès de 296 patients atteints d’un cancer localisé de la prostate traité entre 2014 et 2016, cette étude prospective analyse l’association entre leurs besoins en informations concernant les effets indésirables des traitements et leurs regrets vis-à-vis de la décision thérapeutique
Unmet expectations in prostate cancer patients and their association with decision regret
Menée aux Pays-Bas par questionnaire auprès de 296 patients atteints d’un cancer localisé de la prostate traité entre 2014 et 2016, cette étude prospective analyse l’association entre leurs besoins en informations concernant les effets indésirables des traitements et leurs regrets vis-à-vis de la décision thérapeutique
Unmet expectations in prostate cancer patients and their association with decision regret
Barbara M. Wollersheim, Marie-Anne van Stam, Ruud J.L.H. Bosch (et al.)
Purpose : Information about prostate cancer patients’ experiences with their treatment is crucial to optimize shared decision-making. This study examined unmet expectations in prostate cancer patients and their association with decision regret. Methods : We conducted a prospective, observational, multi-center study of men diagnosed with localized prostate cancer between 2014 and 2016. Questionnaires were completed at baseline (pre-treatment), and up to 12 months after treatment. Unmet [...]
Mené aux Etats-Unis sur 702 patientes atteintes d’un cancer du sein de stade précoce, cet essai randomisé évalue l’intérêt de textos envoyés deux fois par semaine pour améliorer l’adhésion à un traitement adjuvant par inhibiteurs de l’aromatase
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer:...
Mené aux Etats-Unis sur 702 patientes atteintes d’un cancer du sein de stade précoce, cet essai randomisé évalue l’intérêt de textos envoyés deux fois par semaine pour améliorer l’adhésion à un traitement adjuvant par inhibiteurs de l’aromatase
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105
Dawn L. Hershman, Joseph M. Unger, Grace Clarke Hillyer (et al.)
PURPOSE : Nonadherence to aromatase inhibitors (AIs) for breast cancer is common and increases the risk of recurrence. Text messaging increases adherence to medications for chronic conditions. METHODS : We conducted a randomized clinical trial of text messaging (TM) versus no text messaging (No-TM) at 40 sites in the United States. Eligible patients were postmenopausal women with early-stage breast cancer taking an AI for > 30 days with a planned duration of ? 36 months. Test messages were sent [...]
Soins palliatifs (2)
Menée en Corée à partir de données portant sur plus de 600 patients atteints d’un cancer en phase terminale et pris en charge dans des unités de soins palliatifs, cette étude de cohorte rétrospective analyse l’association entre une sédation profonde continue et la durée de survie
Association between continuous deep sedation and survival time in terminally ill cancer patients
Menée en Corée à partir de données portant sur plus de 600 patients atteints d’un cancer en phase terminale et pris en charge dans des unités de soins palliatifs, cette étude de cohorte rétrospective analyse l’association entre une sédation profonde continue et la durée de survie
Association between continuous deep sedation and survival time in terminally ill cancer patients
So-Jung Park, Hee Kyung Ahn, Hong Yup Ahn, Kyu-Tae Han, In Cheol Hwang
Purpose : Our study aimed to evaluate the association between CDS and survival time using the likelihood of receiving CDS to select a matched non-CDS group through an accurate measurement of survival time based on initiation of CDS. Methods : A retrospective cohort study was performed using an electronic database to collect data regarding terminally ill cancer patients admitted to a specialized palliative care unit from January 2012 to December 2016. We first used a Cox proportional hazard [...]
Mené en République tchèque sur 126 patients atteints d’une tumeur solide de stade avancé, cet essai randomisé évalue l’intérêt, du point de vue de la qualité de vie, d’adresser les patients de façon anticipée et systématique à un médecin spécialisé dans les soins palliatifs
Effects of Early and Systematic Integration of Specialist Palliative Care in Patients with Advanced Cancer: Randomized Controlled Trial PALINT
Mené en République tchèque sur 126 patients atteints d’une tumeur solide de stade avancé, cet essai randomisé évalue l’intérêt, du point de vue de la qualité de vie, d’adresser les patients de façon anticipée et systématique à un médecin spécialisé dans les soins palliatifs
Effects of Early and Systematic Integration of Specialist Palliative Care in Patients with Advanced Cancer: Randomized Controlled Trial PALINT
Ondrej Slama, Lukas Pochop, Jiri Sedo, Jan Svancara, Petra Sedova (et al.)
Background: A broad consensus on the optimal structure, intensity, and timing of early specialist palliative care (SPC) intervention is lacking. Objective: To evaluate the benefit of an early and systematic palliative intervention alongside standard oncology care compared with standard oncology care alone in patients with advanced solid tumors. Design: PALINT, a single-center RCT, conducted at the Masaryk Memorial Cancer Institute, the largest comprehensive cancer center in the Czech Republic [...]